Item request has been placed!
×
Item request cannot be made.
×
Processing Request
ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- المؤلفون: Cheli, Yann1 (AUTHOR) ; Tulic, Meri K.2 (AUTHOR); El Hachem, Najla3 (AUTHOR); Nottet, Nicolas1 (AUTHOR); Jacquel, Arnaud4 (AUTHOR); Gesson, Maeva5 (AUTHOR); Strub, Thomas1 (AUTHOR); Bille, Karine1 (AUTHOR); Picard-Gauci, Alexandra6 (AUTHOR); Montaudié, Henri6 (AUTHOR); Beranger, Guillaume E.1,2 (AUTHOR); Passeron, Thierry2,6 (AUTHOR); Close, Pierre3 (AUTHOR); Bertolotto, Corine1 (AUTHOR); Ballotti, Robert1 (AUTHOR)
- المصدر:
Molecular Cancer. 1/7/2021, Vol. 20 Issue 1, p1-5. 5p.
No Comments.